MANINA, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 645
EU - Europa 459
AS - Asia 260
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 1.370
Nazione #
US - Stati Uniti d'America 626
CN - Cina 250
IE - Irlanda 149
UA - Ucraina 90
DE - Germania 54
FI - Finlandia 52
SE - Svezia 46
IT - Italia 29
GB - Regno Unito 26
CA - Canada 19
FR - Francia 7
SG - Singapore 6
AU - Australia 3
BE - Belgio 2
BR - Brasile 2
IN - India 2
RU - Federazione Russa 2
ES - Italia 1
IR - Iran 1
KR - Corea 1
MU - Mauritius 1
RS - Serbia 1
Totale 1.370
Città #
Chandler 167
Dublin 149
Jacksonville 103
Nanjing 65
Ashburn 57
Beijing 48
Boardman 40
Wilmington 25
Jiaxing 21
Nanchang 21
Princeton 21
Changsha 19
Lawrence 19
Medford 19
Tianjin 17
Ottawa 16
Hebei 14
Helsinki 14
Shanghai 14
Shenyang 13
Ann Arbor 11
Falls Church 10
New York 10
Pavia 9
Hangzhou 8
Woodbridge 8
Los Angeles 7
Verona 6
Norwalk 5
Milan 4
Piscataway 3
San Francisco 3
Singapore 3
Brussels 2
Kunming 2
Melbourne 2
Redwood City 2
San Genesio ed Uniti 2
Toronto 2
Washington 2
Aleksinac 1
Auburn Hills 1
Changchun 1
Des Moines 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Guntur 1
Gunzenhausen 1
Houston 1
Huntington 1
Hyderabad 1
Izhevsk 1
Madrid 1
Mississauga 1
Perm 1
Rockville 1
Seattle 1
Seoul 1
Shiraz 1
Sydney 1
Taizhou 1
Totale 985
Nome #
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system 84
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 84
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 83
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 82
Identification of cellular targets of new antitubercular drugs. 79
AN EFFECTIVE NEW DRUG TARGET FOR THE TREATMENT OF TUBERCULOSIS 76
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 75
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 72
Azole drug resistance in Mycobacterium tuberculosis 71
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 71
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 70
NITROREDUCTASE NfnB FROM Mycobacterium smegmatis 69
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 68
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 67
Identification of the cellular target of the potential antitubercular drug BM 212 63
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 60
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 56
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 55
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. 50
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 50
Totale 1.385
Categoria #
all - tutte 4.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 104 0 16 0 16 1 27 2 48 31 1
2020/2021174 21 14 7 17 0 24 0 24 7 25 28 7
2021/2022106 0 1 1 0 7 6 6 6 5 3 15 56
2022/2023424 34 44 1 40 44 40 0 36 169 2 11 3
2023/2024152 14 21 7 13 7 41 2 25 1 8 6 7
2024/202526 4 22 0 0 0 0 0 0 0 0 0 0
Totale 1.385